Desq Long
Sign in

Company

Kura Oncology, Inc.

KURA · CIK 0001422143

SEC FORM 4
$184,500.00

Kura Oncology, Inc. (KURA)

Acquisition (code M) of 30,000 shares at $6.15 per share.

Reporting Person Burrows Francis · Officer Title Chief Scientific Officer · Transaction Code M

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001193125-26-402815 · filed 2026-09-25 · View filing →

SEC FORM 4
$224,514.39

Kura Oncology, Inc. (KURA)

Sale of 20,726 shares at $10.8325 per share.

Reporting Person Burrows Francis · Officer Title Chief Scientific Officer · Transaction Code S

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001193125-26-402815 · filed 2026-09-25 · View filing →

SEC FORM 4
$1,239,000.00

Kura Oncology, Inc. (KURA)

Purchase of 100,000 shares at $12.39 per share.

Reporting Person WILSON TROY EDWARD · Officer Title President and CEO · Transaction Code P

Traded Aug 24, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001193125-26-363812 · filed 2026-08-24 · View filing →

SEC FORM 4
$51,663.35

Kura Oncology, Inc. (KURA)

Sale of 4,345 shares at $11.8903 per share.

Reporting Person Powl Brian T. · Officer Title Chief Commercial Officer · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001193125-26-363810 · filed 2026-08-24 · View filing →

SEC FORM 4
$397,680.81

Kura Oncology, Inc. (KURA)

Sale of 31,487 shares at $12.63 per share.

Reporting Person Bair Teresa Brophy · Officer Title Chief Legal Officer · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001193125-26-361184 · filed 2026-08-21 · View filing →

SEC FORM 4
$1,112,000.00

Kura Oncology, Inc. (KURA)

Purchase of 100,000 shares at $11.12 per share.

Reporting Person WILSON TROY EDWARD · Officer Title President and CEO · Transaction Code P

Traded Aug 17, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001193125-26-354201 · filed 2026-08-17 · View filing →